Get your portfolio ready for Brexit by buying Imperial Brands plc and AstraZeneca plc

Imperial Brands plc (LON:IMB) and AstraZeneca plc (LON:AZN) both offer defensive qualities and growth prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The UK stock market is in for a rough ride in the next month leading up to the EU referendum on 23 June. It’s absolutely key to prepare your portfolio for the volatility expected and both possible outcomes. 

Today I’m looking at two defensive heavyweights Imperial Brands (LSE: IMB) and AstraZeneca (LSE: AZN). 

Tobacco king

The newly-named Imperial Brands has performed excellently over the years in the face of slowing tobacco demand. The company recently released impressive half-year results that CEO Alison Cooper described as “a strong first half performance”. The results included Imperial’s newly-acquired US brands, which have boosted its US market share to 9.3%. In the face of a 3.1% fall in tobacco sales volume the company managed a 21% increase in earnings per share and boosted the dividend by over 9% to 47p a share. 

Imperial has also moved towards the e-cigarette market, this is particularly encouraging as more and more smokers are moving to the ‘healthier’ e-cigarettes. The company also has growth brands such as Winston and Kool, which are gaining market share in the US and should provide growing revenues well into the future. 

Imperial is a classic defensive play and should hold up well during increased periods of market volatility. To add to the defensive qualities, the business is performing well and consistently delivering on all its strategic goals. Add in the 3.8% dividend yield and I think Imperial is a great core holding for any portfolio. 

Exciting pharma 

Another classically defensive industry is the pharmaceutical sector. AstraZeneca has been under pressure for a few years now due to falling revenues and earnings caused by blockbuster drugs coming off patents. However, this is all about to change as AstraZeneca has one of the most exiting drug pipelines in the industry. This potential was indicated when US giant Pfizer came after AstraZeneca a few years ago with a 5,500p offer. 

The company pays a chunky 5% dividend and with earnings set to rise from next year there could be some nice dividend increases to come. The 2016 price-to-earnings ratio is an attractive 13 times, which indicates the stock is somewhat undervalued. The company spends nearly 25% of revenue on R&D which ensures Astra keeps the pipeline of new drugs full. 

AstraZeneca offers a unique investment case due to its strong defensive qualities but also the scope for earnings growth in medium term. There’s also potential for Pfizer or another US pharma giant to return and buy AstraZeneca. I’m not sure management would be so quick to dismiss an offer second time around. 

As the EU referendum in the UK approaches, every investor should be looking at their portfolio and ensuring there are some defensive holdings. Imperial Brands and AstraZeneca are two defensive stocks that should hold up well if the UK votes for Brexit. Importantly, both companies offer medium-term growth prospects, which is rare for defensive stocks. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Dingwall has shares in Imperial Brands. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

3 essential factors for investors to consider when aiming for passive income success

Mark Hartley outlines three of the most important considerations investors are faced with when attempting to secure a lucrative passive…

Read more »

Investing Articles

£10,000 invested in Barclays shares 1 month ago is now worth…

Barclays shares have carried on where they left off in 2024, by climbing far faster than the FTSE 100. Harvey…

Read more »

Investing Articles

I’ve been watching the easyJet share price like a hawk. Here’s what it did last week

Harvey Jones can't take his eyes off the easyJet share price. He thinks it looks good value and ready to…

Read more »

Investing Articles

A £10,000 investment in Nvidia stock 6 months ago is now worth…

Nvidia stock's shown a lot of volatility for a mega-cap company in recent weeks. Dr James Fox explores how an…

Read more »

Investing Articles

4 reasons Ferrari could continue to be a stock market winner

The global luxury goods market may have struggled in recent years, but you wouldn’t guess that from Ferrari’s soaring stock.

Read more »

Investing Articles

5 perfect starter stocks to consider for a Stocks and Shares ISA in 2025

Wondering which shares to buy for a newly opened Stocks and Shares ISA? Our writer thinks these five investments are…

Read more »

Row of terrace houses.
Investing Articles

Thinking about buy-to-let? Consider these UK stocks instead

Owning UK property stocks could be a better way to invest in buy-to-let, though there are drawbacks. Royston Wild explains.

Read more »

Investing Articles

Here’s a plan to target £7,500 a month in passive income

This writer outlines a roadmap that someone could consider taking to try and aim for a substantial future passive income…

Read more »